Amrish Nair, Biorithm – Femom | LSI Asia '25

The company is developing a comprehensive maternity care platform, Femom, to improve perinatal outcomes. The Femom platform merges clinical-grade fetal monitor data with patient reported symptoms and more traditional biometrics (e.g., glucose, blood pressure) to provide clinicians with new insights into the health of the mother and baby.